Prescription Drugs Market Reports

Prescription pharmaceuticals are drugs that cannot be sold over-the-counter without a written directive from a licensed physician.  The global pharmaceutical market was worth approximately $650 billion (at the manufacturer’s level).  The market has continued its recovery from the economic downfall experienced in recent years. Sales for pharmaceuticals increased slightly  The largest therapeutic areas in medicine are: cardiovascular disease and blood disorders, neuroscience, infection, cancer, respiratory and inflammation and others.  The following reports provide market information for prescription pharmaceuticals.  

loading... Loading...
Published: | Price: {{result.PriceString}}
...

No reports match your search criteria.


RSS Subscription
{{ pageDetailsDisplay }}
Published: Aug 19, 2015 | Price: $4,200.00
World Market for Prescription Dermatological Drugs, 9th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments) The worldwide market for prescription dermatological drugs encompasses a wide variety of products that treat disorders of the skin...
Published: Feb 2, 2015 | Price: $3,995.00
The US Market for Rx to OTC Switches Prescription products that are marketed as consumer products are known as Rx-to-OTC. They represent an important part of pharmaceutical strategy and a growing market. This report, The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in...
Published: Jun 18, 2013 | Price: $1,500.00
This report, Out of Pocket Healthcare 2013, is Kalorama's latest estimates for the amount spent by consumers on their own (through cash payments, credit cards, FSAs and finance programs) for healthcare services.   The out-of -pocket market for the following areas are...
Published: Jan 11, 2013 | Price: $3,995.00
The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once only available by prescription.   This report represents the six time that Kalorama Information has analyzed the market for drugs with...
Published: Mar 1, 2012 | Price: $3,995.00
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors that may help to shape...
Published: Feb 1, 2012 | Price: $3,800.00
This Kalorama Information report – The World Market for Anti-Infectives - focuses on three key segments of treatment: Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals) Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones,...
Published: Nov 1, 2011 | Price: $2,995.00
Arthritis is one of the most common human ailments worldwide. Arthritis is a complex family of musculoskeletal disorders with many causes that are not fully understood. The most crippling of the arthritis family is rheumatoid arthritis, which is an autoimmune disease. Successful treatment of...
Published: Feb 1, 2011 | Price: $3,500.00
While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over-the-counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over-the-counter status where...
Published: Apr 1, 2010 | Price: $3,900.00
This Kalorama Information report, Worldwide Market for Prescription Dermatological Drugs details the various categories of prescription dermatological drugs, describes the global market and identifies major market factors that may help to shape the market for treatments in the future. Full...
Published: Oct 1, 2009 | Price: $995.00
At their most basic level, wellness programs represent an attempt to encourage good health and thereby decrease utilization of health care products and services. They have evolved out of necessity from the current U.S. health care system, in response to a variety of factors including continually...
Published: Oct 1, 2009 | Price: $3,500.00
The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness of many antibiotics is waning dramatically, as more and more...
Published: May 1, 2009 | Price: $995.00
While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over the counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over the counter status where...
Published: Feb 1, 2009 | Price: $995.00
Women’s health encompasses all different areas of medicine and it would be a monumental task to address all of the areas that affect women. This report will concentrate on disorders that affect the female reproductive system and other disorders where there is at least a 70% preponderance of...
Published: Jan 1, 2009 | Price: $995.00
This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing...
Published: Jul 1, 2008 | Price: $500.00
Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (China’s pharmaceutical market, for instance, is expected to show double-digit growth over the next five years.) Developing...
Published: Apr 1, 2008 | Price: $500.00
Lagging FDA approvals led to a brief absence of Rx to OTC switches in the pharmaceutical marketplace, but 2006 and 2007 saw a number of switches, and Kalorama Information believes this product management tactic will continue to be aggressively utilized as companies seek ways to extend revenue life....
Published: Apr 1, 2008 | Price: $995.00
Generics, so long the force that has shaken up the branded pharmaceutical industry, is now facing its own challenges as an industry. While growth indications are strong, there are challenges for generic companies. In the next two years, consolidation will most likely rise; the sector is expected...
Published: Mar 15, 2008 | Price: $6,995.00
Pharmaceutical marketers will face a challenging time in 2008 by all reports. Understanding the dynamics of the market can assist in better planning and strategy. This Kalorama Information Report Bundle combines 5 of the most important topics for those in the pharmaceutical industry in a...
Published: Feb 1, 2008 | Price: $895.00
Congestive heart failure is an increasingly important cause of cardiovascular morbidity and mortality. It is the number one cause of hospitalization among individuals aged 65 and over. The United States Medicare system pays out more for the care of congestive heart failure than it does for all...
Published: Jan 1, 2008 | Price: $995.00
Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system, multisystemic tissue, and connective tissues. Although a range of autoimmune conditions carry a low prevalence, combined these diseases amount to a growing medical and economic burden. ...
Published: Jan 1, 2008 | Price: $4,200.00
One of Kalorama's best-selling market research reports, this report provides the reader with a complete analysis of the domestic and international markets for pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatological Drugs is the sixth...
Published: Jan 1, 2008 | Price: $995.00
Although much of medicine is focused on the increased aging of the population, children still represent the bulk the dependent population worldwide. Important regulatory factors are at work in the pediatric pharmaceutical market. The recognition of the rights of children to have access to safe...
Published: Dec 1, 2007 | Price: $995.00
Kalorama's 2nd edition of The World Cardiovascular Drugs Market, in its 2nd edition, will steer marketers through the sheer size and diversity of the current market and the potential of new products that will make this therapeutic category among the most competitive of prescription drug segments. ...
Published: Oct 1, 2007 | Price: $995.00
It can be said that pharmaceutical companies face a 'new era.' in the coming years. Old strategies will not produce the same results. A wave of generic competition is poised to affect most brands. Drug companies have had to cut research budgets, leading to a dearth of new products on the...
Published: Oct 1, 2007 | Price: $995.00
In five years, Kalorama Information believes that given the role of pharmacists currently and the demands of the US healthcare system, pharmacists will be prescribing in at least six states in five years, creating a trend that will spread to many other states in following years. The state of...
Published: | Price: {{result.PriceString}}
...
{{ pageDetailsDisplay }}

No reports match your search criteria.